Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.

Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.
Biol Proced Online. 2017;19:2
Authors: Lu Y, Li S, Zhu S, Gong Y, Shi J, Xu L
Abstract
DNA/RNA methylation plays an important role in lung cancer initiation and progression. Liquid biopsy makes use of cells, nucleotides and proteins released from tumor cells into body fluids to help with cancer diagnosis and prognosis. Methylation of circulating tumor DNA (ctDNA) has gained increasing attention as biomarkers for lung cancer. Here we briefly introduce the biological basis and detection method of ctDNA methylation, and review various applications of methylated DNA in body fluids in lung cancer screening, diagnosis, prognosis, monitoring and treatment prediction. We also discuss the emerging role of RNA methylation as biomarkers for cancer.
PMID: 28331435 [PubMed]

Source: Biological Procedures Online - March 25, 2017 Category: Molecular Biology Authors: Lu Y, Li S, Zhu S, Gong Y, Shi J, Xu L Tags: Biol Proced Online Source Type: research